Cargando…
ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective
The advent of early absorption, distribution, metabolism, excretion, and toxicity (ADMET) screening has increased the attrition rate of weak drug candidates early in the drug-discovery process, and decreased the proportion of compounds failing in clinical trials for ADMET reasons. This paper reviews...
Autores principales: | Tsaioun, Katya, Bottlaender, Michel, Mabondzo, Aloise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697629/ https://www.ncbi.nlm.nih.gov/pubmed/19534730 http://dx.doi.org/10.1186/1471-2377-9-S1-S1 |
Ejemplares similares
-
The Most Common Mistake in Laryngeal Pathology and How to Avoid it
por: Heidarian, Amin, et al.
Publicado: (2021) -
Some Dangers and Mistakes to Be Avoided
Publicado: (1914) -
Pandemics: avoiding the mistakes of 1918
por: Barry, John M.
Publicado: (2009) -
Interfacing medicinal chemistry with structural bioinformatics: implications for T box riboswitch RNA drug discovery
por: Jentzsch, Franziska, et al.
Publicado: (2012) -
Occurrence of Morpholine in Central Nervous System
Drug Discovery
por: Lenci, Elena, et al.
Publicado: (2021)